Why is AtriCure, Inc. ?
- The company has declared positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 57.34 MM
- ROCE(HY) Highest at -2.4%
- RAW MATERIAL COST(Y) Fallen by -0.71% (YoY)
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
How much should you buy?
- Overall Portfolio exposure to AtriCure, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is AtriCure, Inc. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 57.34 MM
Highest at -2.4%
Fallen by -0.71% (YoY
Lowest at -18.48 %
Highest at 1.78 times
Highest at 8.42 times
Highest at USD 140.5 MM
Highest at USD 8.6 MM
Highest at 6.12 %
Highest at USD 3.36 MM
Highest at USD 2.5 MM
Highest at USD 0.04
Here's what is working for AtriCure, Inc.
Pre-Tax Profit (USD MM)
Operating Cash Flows (USD MM)
Net Profit (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Debt-Equity Ratio
Inventory Turnover Ratio
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales






